USE OF DACLIZUMAB (ZENAPAX) AS INITIAL IMMUNOSUPPRESSION IN LIVER TRANSPLANT RECIPIENTS WITH KIDNEY FAILURE
- 1 May 1999
- journal article
- Published by Wolters Kluwer Health in Transplantation
- Vol. 67 (9) , S600
- https://doi.org/10.1097/00007890-199905150-00255
Abstract
No abstract availableThis publication has 0 references indexed in Scilit: